JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged)

WKN A2PR3Z | ISIN LU2053353582 |  Fonds
Factsheet
24.04.25
74,47 CHF-1,09 % (-0,82)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU2036818289 CPR Invest - MedTech - H USD - Acc +7,94 % +14,46 % 0,40
2 LU2194372939 Bellevue Funds (Lux) - Bellevue Medtech & Services U2 USD - Accumulating +5,76 % +14,93 % 0,24
3 LU2194372855 Bellevue Funds (Lux) - Bellevue Medtech & Services U USD - Accumulating +5,45 % +14,93 % 0,22
4 BE0170813936 KBC Equity Fund Medical Technologies Classic +5,06 % +13,38 % 0,22
5 LU2107455052 Bellevue Funds (Lux) - Bellevue Medtech & Services I2 USD - Accumulating +5,39 % +14,93 % 0,22
344 LU2053353582 JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged) -17,23 % +24,14 % -0,80
444 LU2425425506 Candriam Equities L Oncology, V - Capitalisation -13,89 % +12,98 % -1,24
445 IE00BF2ZTL15 Wellington Global Health Care Equity Fund CHF D AccU -17,38 % +15,73 % -1,24
446 LU1864482515 Candriam Equities L Oncology, I - Capitalisation -14,16 % +12,98 % -1,26
447 LU1864482945 Candriam Equities L Oncology, R - Capitalisation -14,24 % +12,98 % -1,26
448 LU2275059405 DNB Fund - Health Care Retail A (SEK) -16,83 % +13,90 % -1,37